![]() | |
Names | |
---|---|
IUPAC name 6β--17-(cyclopropylmethyl)-4,5α-epoxymorphinan-3,14-diol | |
Systematic IUPAC name (4R,4aS,7R,7aR,12bS)-7--3-(cyclopropylmethyl)-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuroisoquinoline-4a,9-diol | |
Other names α-Chlornaltrexamine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider |
|
PubChem CID | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C24H32Cl2N2O3 |
Molar mass | 467.43 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
![]() ![]() ![]() |
Chlornaltrexamine is an irreversible mixed agonist–antagonist for μ-opioid receptors, which forms a covalent bond to the binding site. It is 22 times more potent than morphine. Its alkylating group is a bis(chloroalkyl)amino-residue similar to that of the nitrogen mustards.
![]() | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |